source
- Xenon pauses enrollment in phase 3 depression trials after reports of psychosis and other neuropsychiatric eventsXenon Pharmaceuticals announced it has voluntarily stopped enrolling new patients in its two phase 3 studies of azetukalner for major depressive disorder and bipolar depression. The decision follo…
- Spectra Medical recalls Sodium Chloride Flush ampules due to serious safety riskSpectra Medical Devices has issued a recall of its Sodium Chloride Injection 0.9% USP 10 mL flush ampules that were manufactured by Huons Co., Ltd. The FDA classified the recall as the most serious…